Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Sponsors » Genomics: Clinical Implementation » Sema4 Nabs New York State Approval for Cancer Somatic Sequencing Tests

Sema4 Nabs New York State Approval for Cancer Somatic Sequencing Tests

Jul 15, 2020
|
staff reporter

NEW YORK ─ Sema4 said on Wednesday that it has secured approval from the New York State Department of Health to conduct its Sema4 Signal Whole Exome/Transcriptome Sequencing (WES/WTS) and PanCancer somatic tests.

The firm said it believes it is the first company with a commercial laboratory to be approved by the NYS DOH for WES/WTS for solid and hematologic malignancies using tumor-normal analysis.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

From the Recovered

According to the Wall Street Journal, the Food and Drug Administration may soon issue an Emergency Use Authorization for convalescent plasma to treat COVID-19 patients.

Minnesota Cold Case Arrest

Minnesota police have used genetic genealogy to make an arrest in a 1986 cold case, reports NBC News.

Editing Squid

Researchers have used CRISPR-Cas9 to efficiently target a cephalopod pigmentation gene, as they report in Current Biology.

Science Papers Examine Human Fetal Microglia Development, Structure of Adenine Base Editor ABE8e

In Science this week: chromatin accessibility of microglia during fetal development, and more.

What's Popular?

In Regulatory News & FDA Approvals

  1. FDA Grants Emergency Use Authorization for Eli Lilly, Sandia National Labs Coronavirus PCR Tests

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.